Edmond De Rothschild Holding S.A. Akebia Therapeutics, Inc. Transaction History
Edmond De Rothschild Holding S.A.
- $5.87 Billion
- Q1 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 50,000 shares of AKBA stock, worth $48,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000
Previous 50,000
-0.0%
Holding current value
$48,000
Previous $62,000
46.77%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AKBA
# of Institutions
127Shares Held
56.7MCall Options Held
937KPut Options Held
743K-
Satter Management Co., L.P.13.2MShares$12.7 Million26.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$7.9 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA5.31MShares$5.1 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.65MShares$3.51 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.27MShares$3.14 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $176M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...